Charles Schwab Investment Management Inc. Sells 15,307 Shares of Proto Labs, Inc. $PRLB

Key Points

• Charles Schwab Investment Management Inc. reduced its stake in Proto Labs, Inc. by 5.3%, holding now 274,038 shares, valued at approximately $9.6 million.
• Proto Labs reported $0.41 EPS for the last quarter, surpassing estimates, with a 7.6% increase in revenue year-over-year, totaling $135.06 million.
• Analysts recently upgraded Proto Labs to a "strong-buy" rating, with a consensus price target now set at $52.50.

Charles Schwab Investment Management Inc. decreased its holdings in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 5.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 274,038 shares of the industrial products company's stock after selling 15,307 shares during the period. Charles Schwab Investment Management Inc. owned about 1.15% of Proto Labs worth $9,602,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. GAMMA Investing LLC increased its holdings in shares of Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 661 shares during the period. Quarry LP increased its holdings in shares of Proto Labs by 175.7% in the 4th quarter. Quarry LP now owns 1,585 shares of the industrial products company's stock valued at $62,000 after purchasing an additional 1,010 shares during the period. CWM LLC increased its holdings in shares of Proto Labs by 50.4% in the 1st quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock valued at $64,000 after purchasing an additional 617 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Proto Labs by 14.1% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock valued at $76,000 after purchasing an additional 267 shares during the period. Finally, LPL Financial LLC acquired a new position in shares of Proto Labs in the 4th quarter valued at about $210,000. Institutional investors and hedge funds own 84.54% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on PRLB. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 target price on the stock in a report on Friday, August 1st. Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Finally, Cantor Fitzgerald increased their price objective on Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday, August 1st. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Proto Labs presently has a consensus rating of "Moderate Buy" and an average price target of $52.50.

Proto Labs Price Performance

NYSE:PRLB traded down $1.08 during mid-day trading on Friday, reaching $49.69. The stock had a trading volume of 207,182 shares, compared to its average volume of 185,243. The business's 50 day moving average is $43.29 and its 200 day moving average is $39.47. Proto Labs, Inc. has a fifty-two week low of $26.34 and a fifty-two week high of $51.09. The stock has a market cap of $1.19 billion, a P/E ratio of 82.81 and a beta of 1.27.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.33 by $0.08. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The firm had revenue of $135.06 million for the quarter, compared to the consensus estimate of $128.05 million. During the same quarter in the prior year, the company posted $0.38 earnings per share. The firm's revenue was up 7.6% on a year-over-year basis. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Equities analysts expect that Proto Labs, Inc. will post 0.81 EPS for the current year.

Insider Transactions at Proto Labs

In related news, CEO Suresh Krishna bought 1,725 shares of the firm's stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $43.51 per share, with a total value of $75,054.75. Following the completion of the transaction, the chief executive officer directly owned 18,021 shares of the company's stock, valued at $784,093.71. This trade represents a 10.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.20% of the stock is owned by insiders.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.